Antidepressant Use and Cognitive Decline: The Health and Retirement Study

被引:39
作者
Saczynski, Jane S. [1 ,2 ,3 ]
Rosen, Allison B. [2 ,3 ]
McCammon, Ryan J. [4 ]
Zivin, Kara [5 ,6 ,7 ,8 ]
Andrade, Susan E. [2 ]
Langa, Kenneth M. [4 ,6 ,8 ]
Vijan, Sandeep [4 ,6 ]
Pirraglia, Paul A. [9 ]
Briesacher, Becky A. [10 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[2] Meyers Primary Care Inst, Worcester, MA USA
[3] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA
[4] Univ Michigan, Sch Med, Dept Med, Div Gen Med, Ann Arbor, MI 48104 USA
[5] Natl Serious Mental Illness Treatment Resource &, Dept Vet Affairs, Ann Arbor, MI USA
[6] Ctr Clin Management Res, Dept Vet Affairs, Ann Arbor, MI USA
[7] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI USA
[8] Univ Michigan, Inst Social Res, Ann Arbor, MI USA
[9] Brown Univ, Dept Med, Alpert Sch Med, Providence, RI 02912 USA
[10] Northeastern Univ, Dept Pharm & Hlth Syst Sci, Boston, MA 02115 USA
关键词
Antidepressants; Cognition; Depression; Epidemiology; DEPRESSIVE SYMPTOMS; RISK-FACTOR; ANTICHOLINERGIC PROPERTIES; DOUBLE-BLIND; IMPAIRMENT; DEMENTIA; HISTORY; DISEASE; DEMOGRAPHICS; MEDICATIONS;
D O I
10.1016/j.amjmed.2015.01.007
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND: Depression is associated with cognitive impairment and dementia, but whether treatment for depression with antidepressants reduces the risk for cognitive decline is unclear. We assessed the association between antidepressant use and cognitive decline over 6 years. METHODS: Participants were 3714 adults aged 50 years or more who were enrolled in the nationally representative Health and Retirement Study and had self-reported antidepressant use. Depressive symptoms were assessed using the 8-item Center for Epidemiologic Studies Depression Scale. Cognitive function was assessed at 4 time points (2004, 2006, 2008, 2010) using a validated 27-point scale. Change in cognitive function over the 6-year follow-up period was examined using linear growth models, adjusted for demographics, depressive symptoms, comorbidities, functional limitations, and antidepressant anticholinergic activity load. RESULTS: At baseline, cognitive function did not differ significantly between the 445 (12.1%) participants taking antidepressants and those not taking antidepressants (mean, 14.9%; 95% confidence interval, 14.3-15.4 vs mean, 15.1%; 95% confidence interval, 14.9-15.3). During the 6-year follow up period, cognition declined in both users and nonusers of antidepressants, ranging from -1.4 change in mean score in those with high depressive symptoms and taking antidepressants to -0.5 change in mean score in those with high depressive symptoms and not taking antidepressants. In adjusted models, cognition declined in people taking antidepressants at the same rate as those not taking antidepressants. Results remained consistent across different levels of baseline cognitive function, age, and duration of antidepressant use (prolonged vs short-term). CONCLUSIONS: Antidepressant use did not modify the course of 6-year cognitive change in this nationally representative sample. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:739 / 746
页数:8
相关论文
共 39 条
[1]
Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study [J].
Ancelin, ML ;
Artero, S ;
Portet, F ;
Dupuy, AM ;
Touchon, J ;
Ritchie, K .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7539) :455-458
[2]
Depressive symptoms, vascular disease, and mild cognitive impairment - Findings from the cardiovascular health study [J].
Barnes, DE ;
Alexopoulos, GS ;
Lopez, OL ;
Williamson, JD ;
Yaffe, K .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (03) :273-280
[3]
Long-term cognitive impact of anticholinergic medications in older adults [J].
Bottiggi, Kara A. ;
Salazar, Juan C. ;
Yu, Lei ;
Caban-Holt, Allison M. ;
Ryan, Melody ;
Mendiondo, Marta S. ;
Schmitt, Frederick A. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (11) :980-984
[4]
Changes in cognitive functioning following treatment of late-life depression [J].
Butters, MA ;
Becker, JL ;
Nebes, RD ;
Zmuda, MD ;
Mulsant, BH ;
Pollock, BG ;
Reynolds, CF .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (12) :1949-1954
[5]
Use of anticholinergics and the risk of cognitive impairment in an African American population [J].
Campbell, N. L. ;
Boustani, M. A. ;
Lane, K. A. ;
Gao, S. ;
Hendrie, H. ;
Khan, B. A. ;
Murrell, J. R. ;
Unverzagt, F. W. ;
Hake, A. ;
Smith-Gamble, V. ;
Hall, K. .
NEUROLOGY, 2010, 75 (02) :152-159
[6]
The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity [J].
Carnahan, Ryan M. ;
Lund, Brian C. ;
Perry, Paul J. ;
Pollock, Bruce G. ;
Culp, Kennith R. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12) :1481-1486
[7]
Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population The 3-City Study [J].
Carriere, Isabelle ;
Fourrier-Reglat, Annie ;
Dartigues, Jean-Francois ;
Rouaud, Olivier ;
Pasquier, Florence ;
Ritchie, Karen ;
Ancelin, Marie-Laure .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (14) :1317-+
[8]
Assessment of Cognition Using Surveys and Neuropsychological Assessment: The Health and Retirement Study and the Aging, Demographics, and Memory Study [J].
Crimmins, Eileen M. ;
Kim, Jung Ki ;
Langa, Kenneth M. ;
Weir, David R. .
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2011, 66 :162-171
[9]
Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression [J].
Culang, Michelle E. ;
Sneed, Joel R. ;
Keilp, John G. ;
Rutherford, Bret R. ;
Pelton, Gregory H. ;
Devanand, D. P. ;
Roose, Steven P. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (10) :881-888
[10]
Sertraline treatment of elderly patients with depression and cognitive impairment [J].
Devanand, DP ;
Pelton, DH ;
Marston, K ;
Camacho, Y ;
Roose, SP ;
Stern, Y ;
Sackeim, HA .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (02) :123-130